隧道式血液透析导管插入前预防性抗生素:一项全国性队列研究。

IF 3.4 Q1 UROLOGY & NEPHROLOGY
Kidney Medicine Pub Date : 2025-06-02 eCollection Date: 2025-08-01 DOI:10.1016/j.xkme.2025.101042
Benjamin Lazarus, Sradha Kotwal, Martin Gallagher, Kathryn Higgins, Sarah Coggan, Nicholas A Gray, Girish Talaulikar, Kevan R Polkinghorne
{"title":"隧道式血液透析导管插入前预防性抗生素:一项全国性队列研究。","authors":"Benjamin Lazarus, Sradha Kotwal, Martin Gallagher, Kathryn Higgins, Sarah Coggan, Nicholas A Gray, Girish Talaulikar, Kevan R Polkinghorne","doi":"10.1016/j.xkme.2025.101042","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale & objective: </strong>It is unknown whether administration of prophylactic systemic antibiotics immediately before tunneled catheter insertion can prevent early hemodialysis catheter-related bloodstream infections (HDCRBSI). We aimed to estimate the effect of systemic prophylactic antibiotics on early HDCRBSI.</p><p><strong>Study design: </strong>An observational secondary analysis using data from the nationwide REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach trial.</p><p><strong>Setting & participants: </strong>Adults with an incident hemodialysis catheter inserted in one of 37 Australian nephrology services from December 2016 to March 2020.</p><p><strong>Exposure: </strong>Service-wide policy of systemic prophylactic antibiotic use before tunneled catheter insertion determined by response to a prestudy survey.</p><p><strong>Outcome: </strong>HDCRBSI within 14 days of catheter insertion, independently adjudicated by a blinded panel using modified Infectious Diseases Society of America criteria.</p><p><strong>Analytical approach: </strong>Multilevel logistic regression to compare outcomes among antibiotic-using and nonusing services.</p><p><strong>Results: </strong>Six services (900 patients) used prophylactic antibiotics, and 23 services (3,702 patients) did not. Among the 1,196 tunneled catheters that were inserted in antibiotic-using services, 4 (0.3%) had HDCRBSI and another 10 (0.8%) had infectious removal within 14 days of insertion. Among the 5,027 tunneled catheters inserted in nonantibiotic-using services, 40 (0.8%) had HDCRBSI and another 41 (0.8%) had infectious removal within 14 days. The odds of early HDCRBSI were not significantly different between antibiotic-using and nonusing services in the unadjusted (OR, 0.42; 95% CI, 0.15-1.17) or adjusted models (adjusted OR, 0.59; 95% CI, 0.20-1.80).</p><p><strong>Limitations: </strong>Prophylactic systemic antibiotic use was determined at a service level and was not randomly assigned to individuals.</p><p><strong>Conclusions: </strong>In Australia, less than 1% of tunneled catheters had confirmed HDCRBSI within 14 days of insertion. Routine administration of prophylactic antibiotics before insertion of tunneled cuffed catheters was not associated with a reduced occurrence of early HDCRBSI within 14 days.</p>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":"7 8","pages":"101042"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304927/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prophylactic Antibiotics Before Insertion of Tunneled Hemodialysis Catheters: A Nationwide Cohort Study.\",\"authors\":\"Benjamin Lazarus, Sradha Kotwal, Martin Gallagher, Kathryn Higgins, Sarah Coggan, Nicholas A Gray, Girish Talaulikar, Kevan R Polkinghorne\",\"doi\":\"10.1016/j.xkme.2025.101042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Rationale & objective: </strong>It is unknown whether administration of prophylactic systemic antibiotics immediately before tunneled catheter insertion can prevent early hemodialysis catheter-related bloodstream infections (HDCRBSI). We aimed to estimate the effect of systemic prophylactic antibiotics on early HDCRBSI.</p><p><strong>Study design: </strong>An observational secondary analysis using data from the nationwide REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach trial.</p><p><strong>Setting & participants: </strong>Adults with an incident hemodialysis catheter inserted in one of 37 Australian nephrology services from December 2016 to March 2020.</p><p><strong>Exposure: </strong>Service-wide policy of systemic prophylactic antibiotic use before tunneled catheter insertion determined by response to a prestudy survey.</p><p><strong>Outcome: </strong>HDCRBSI within 14 days of catheter insertion, independently adjudicated by a blinded panel using modified Infectious Diseases Society of America criteria.</p><p><strong>Analytical approach: </strong>Multilevel logistic regression to compare outcomes among antibiotic-using and nonusing services.</p><p><strong>Results: </strong>Six services (900 patients) used prophylactic antibiotics, and 23 services (3,702 patients) did not. Among the 1,196 tunneled catheters that were inserted in antibiotic-using services, 4 (0.3%) had HDCRBSI and another 10 (0.8%) had infectious removal within 14 days of insertion. Among the 5,027 tunneled catheters inserted in nonantibiotic-using services, 40 (0.8%) had HDCRBSI and another 41 (0.8%) had infectious removal within 14 days. The odds of early HDCRBSI were not significantly different between antibiotic-using and nonusing services in the unadjusted (OR, 0.42; 95% CI, 0.15-1.17) or adjusted models (adjusted OR, 0.59; 95% CI, 0.20-1.80).</p><p><strong>Limitations: </strong>Prophylactic systemic antibiotic use was determined at a service level and was not randomly assigned to individuals.</p><p><strong>Conclusions: </strong>In Australia, less than 1% of tunneled catheters had confirmed HDCRBSI within 14 days of insertion. Routine administration of prophylactic antibiotics before insertion of tunneled cuffed catheters was not associated with a reduced occurrence of early HDCRBSI within 14 days.</p>\",\"PeriodicalId\":17885,\"journal\":{\"name\":\"Kidney Medicine\",\"volume\":\"7 8\",\"pages\":\"101042\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304927/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kidney Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.xkme.2025.101042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xkme.2025.101042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

理由与目的:目前尚不清楚在隧道导管插入前立即给予预防性全身抗生素是否可以预防早期血液透析导管相关血流感染(HDCRBSI)。我们的目的是评估系统性预防性抗生素对早期HDCRBSI的影响。研究设计:一项观察性的二次分析,使用来自全国范围内减轻透析导管并发症负担的数据:一项全国方法试验。环境和参与者:2016年12月至2020年3月期间,在澳大利亚37家肾脏病服务机构之一插入意外血液透析导管的成年人。暴露:通过对研究前调查的反应确定了在隧道导管插入前系统预防性抗生素使用的服务范围政策。结果:导管插入14天内HDCRBSI,由一个盲法小组使用修改的美国传染病学会标准独立裁定。分析方法:多水平逻辑回归比较使用和不使用抗生素服务的结果。结果:6家医院(900例)使用预防性抗生素,23家医院(3702例)未使用预防性抗生素。在使用抗生素的服务中插入的1196个隧道导管中,4个(0.3%)有HDCRBSI,另外10个(0.8%)在插入后14天内有感染性移除。在非抗生素服务中插入的5027个隧道导管中,40个(0.8%)有HDCRBSI,另外41个(0.8%)在14天内清除了感染。早期HDCRBSI的几率在未调整的使用抗生素和不使用抗生素的服务之间没有显著差异(OR, 0.42;95% CI, 0.15-1.17)或校正模型(校正or, 0.59;95% ci, 0.20-1.80)。局限性:预防性全身性抗生素的使用是在服务水平上确定的,并不是随机分配给个人的。结论:在澳大利亚,不到1%的隧道导管在插入14天内确诊HDCRBSI。在插入隧道套管导管前常规给予预防性抗生素与14天内早期HDCRBSI发生率的降低无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prophylactic Antibiotics Before Insertion of Tunneled Hemodialysis Catheters: A Nationwide Cohort Study.

Rationale & objective: It is unknown whether administration of prophylactic systemic antibiotics immediately before tunneled catheter insertion can prevent early hemodialysis catheter-related bloodstream infections (HDCRBSI). We aimed to estimate the effect of systemic prophylactic antibiotics on early HDCRBSI.

Study design: An observational secondary analysis using data from the nationwide REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach trial.

Setting & participants: Adults with an incident hemodialysis catheter inserted in one of 37 Australian nephrology services from December 2016 to March 2020.

Exposure: Service-wide policy of systemic prophylactic antibiotic use before tunneled catheter insertion determined by response to a prestudy survey.

Outcome: HDCRBSI within 14 days of catheter insertion, independently adjudicated by a blinded panel using modified Infectious Diseases Society of America criteria.

Analytical approach: Multilevel logistic regression to compare outcomes among antibiotic-using and nonusing services.

Results: Six services (900 patients) used prophylactic antibiotics, and 23 services (3,702 patients) did not. Among the 1,196 tunneled catheters that were inserted in antibiotic-using services, 4 (0.3%) had HDCRBSI and another 10 (0.8%) had infectious removal within 14 days of insertion. Among the 5,027 tunneled catheters inserted in nonantibiotic-using services, 40 (0.8%) had HDCRBSI and another 41 (0.8%) had infectious removal within 14 days. The odds of early HDCRBSI were not significantly different between antibiotic-using and nonusing services in the unadjusted (OR, 0.42; 95% CI, 0.15-1.17) or adjusted models (adjusted OR, 0.59; 95% CI, 0.20-1.80).

Limitations: Prophylactic systemic antibiotic use was determined at a service level and was not randomly assigned to individuals.

Conclusions: In Australia, less than 1% of tunneled catheters had confirmed HDCRBSI within 14 days of insertion. Routine administration of prophylactic antibiotics before insertion of tunneled cuffed catheters was not associated with a reduced occurrence of early HDCRBSI within 14 days.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信